Correlation Between SAB Biotherapeutics and Indaptus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SAB Biotherapeutics and Indaptus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SAB Biotherapeutics and Indaptus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SAB Biotherapeutics and Indaptus Therapeutics, you can compare the effects of market volatilities on SAB Biotherapeutics and Indaptus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SAB Biotherapeutics with a short position of Indaptus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SAB Biotherapeutics and Indaptus Therapeutics.

Diversification Opportunities for SAB Biotherapeutics and Indaptus Therapeutics

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between SAB and Indaptus is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding SAB Biotherapeutics and Indaptus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Indaptus Therapeutics and SAB Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SAB Biotherapeutics are associated (or correlated) with Indaptus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Indaptus Therapeutics has no effect on the direction of SAB Biotherapeutics i.e., SAB Biotherapeutics and Indaptus Therapeutics go up and down completely randomly.

Pair Corralation between SAB Biotherapeutics and Indaptus Therapeutics

Assuming the 90 days horizon SAB Biotherapeutics is expected to generate 25.15 times more return on investment than Indaptus Therapeutics. However, SAB Biotherapeutics is 25.15 times more volatile than Indaptus Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Indaptus Therapeutics is currently generating about -0.02 per unit of risk. If you would invest  2.10  in SAB Biotherapeutics on November 2, 2024 and sell it today you would earn a total of  1.58  from holding SAB Biotherapeutics or generate 75.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy79.03%
ValuesDaily Returns

SAB Biotherapeutics  vs.  Indaptus Therapeutics

 Performance 
       Timeline  
SAB Biotherapeutics 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SAB Biotherapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, SAB Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Indaptus Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Indaptus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in March 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

SAB Biotherapeutics and Indaptus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SAB Biotherapeutics and Indaptus Therapeutics

The main advantage of trading using opposite SAB Biotherapeutics and Indaptus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SAB Biotherapeutics position performs unexpectedly, Indaptus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will offset losses from the drop in Indaptus Therapeutics' long position.
The idea behind SAB Biotherapeutics and Indaptus Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Transaction History
View history of all your transactions and understand their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins